Our study focused on aldose reductase inhibition, antidiabetic, anti-inflammatory, and antioxidant properties, essential for managing diabetes by addressing glycemic control, oxidative stress, and inflammation. The gene discussed is AKR1B1; the disease is diabetes mellitus.